OPKO Health (OPK) Tops Q4 EPS by 1c

OPKO Health (NASDAQ: OPK) reported Q4 EPS of ($0.09), $0.01 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $181.9 million versus the consensus estimate of $177.53 million.

For earnings history and earnings-related data on OPKO Health (OPK) click here.

You May Also Be Interested In

• CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance
• Metalla Royalty & Streaming Ltd. (MTA) Reports In-Line Q2 EPS
• Immucell Corp (ICCC) Reports Q2 EPS of $0.20